January 4, 2024 · Form 4 insider transaction
Nachman Shlomo bought 5,322 shares of AtriCure, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest 33% annually over three years from the date of grant.